These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6754212)

  • 21. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.
    Graham-Pole J; Weare J; Engel S; Gardner R; Mehta P; Gross S
    J Clin Oncol; 1986 Jul; 4(7):1110-3. PubMed ID: 3522818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
    Salvo N; Doble B; Khan L; Amirthevasar G; Dennis K; Pasetka M; Deangelis C; Tsao M; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):408-17. PubMed ID: 21075553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
    Priestman TJ; Priestman SG
    Clin Radiol; 1984 Jul; 35(4):265-6. PubMed ID: 6329586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
    Diasio RB; Ettinger DS; Satterwhite BE
    J Clin Pharmacol; 1981; 21(S1):81S-85S. PubMed ID: 7298876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics.
    Kenny JB; Wilkinson PM
    Clin Oncol; 1982 Dec; 8(4):335-9. PubMed ID: 7168926
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
    Tramèr MR; Reynolds DJ; Stoner NS; Moore RA; McQuay HJ
    Eur J Cancer; 1998 Nov; 34(12):1836-44. PubMed ID: 10023303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
    Zylberait D; Krulik M; Audebert AA; Debray J
    Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study.
    Ganesh V; Chan S; Zhang L; Drost L; DeAngelis C; Wan BA; Pasetka M; Tsao M; Barnes E; Pulenzas N; Chung H; Zaki P; Yee C; Chow E
    Ann Palliat Med; 2018 Oct; 7(4):385-392. PubMed ID: 30180723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron: a review of its use as an antiemetic in children.
    Culy CR; Bhana N; Plosker GL
    Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
    Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
    BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latest advances in the management of radiation-induced pain flare, nausea and vomiting.
    Chiu N; Chiu L; Popovic M; DeAngelis C; Pasetka M; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
    Ann Palliat Med; 2016 Jan; 5(1):50-7. PubMed ID: 26841815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
    McKenzie E; Zaki P; Raman S; Olson R; McFarlane T; DeAngelis C; Chan S; Pidduck W; Razvi Y; Bushehri A; Chow E
    Support Care Cancer; 2019 Mar; 27(3):783-791. PubMed ID: 30607675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing chemotherapy-induced nausea and vomiting in head and neck cancer patients receiving cisplatin chemotherapy with concurrent radiation.
    Stinson J; Chan K; Lee J; Chow R; Cheon P; Giotis A; Pasetka M; Wan BA; Chow E; DeAngelis C
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S13-S20. PubMed ID: 28595433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment implications for radiation-induced nausea and vomiting in specific patient groups.
    Horiot JC; Aapro M
    Eur J Cancer; 2004 May; 40(7):979-87. PubMed ID: 15093572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
    Ungerleider JT; Andrysiak TA; Fairbanks LA; Tesler AS; Parker RG
    Radiology; 1984 Feb; 150(2):598-9. PubMed ID: 6318262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer.
    Bubalo JS; Herrington JD; Takemoto M; Willman P; Edwards MS; Williams C; Fisher A; Palumbo A; Chen E; Blanke C; Lopez CD
    Support Care Cancer; 2018 Apr; 26(4):1273-1279. PubMed ID: 29090385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.